뉴스벤징가
Structure Therapeutics Advances Weight-Loss Pills With New Clinical Data
· 발표
기사 요약
Structure Therapeutics (NASDAQ: GPCR) reports strong clinical trial data for oral weight loss candidates ACCG-2671 and aleniglipron.
기사 원문에서 발췌했어요.Structure Therapeutics (NASDAQ: GPCR) reports strong clinical trial data for oral weight loss candidates ACCG-2671 and aleniglipron.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…